Interleukin-10-deficient mice develop chronic enterocolitis

[1]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[2]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[3]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.

[4]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[5]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[6]  Andreas Radbruch,et al.  Regulation of T helper cell cytokine expression: functional dichotomy of antigen‐presenting cells , 1993, European journal of immunology.

[7]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[8]  S. Krantz,et al.  Progress in understanding the pathogenesis of the anemia of chronic disease. , 1992, Blood.

[9]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Umetsu,et al.  Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones. , 1992, Journal of immunology.

[11]  F. Finkelman,et al.  The Importance of Th2 Cytokines in Protective Immunity to Nematodes , 1992, Immunological reviews.

[12]  J. Berzofsky,et al.  Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.

[13]  N. Copeland,et al.  Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. , 1992, Journal of immunology.

[14]  M. Howard,et al.  Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells , 1992, The Journal of experimental medicine.

[15]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[16]  M. Howard,et al.  Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.

[17]  J. Banchereau,et al.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[19]  R. Coffman,et al.  Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.

[20]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[21]  A. Lindahl,et al.  Growth and differentiation. , 1991, Bailliere's clinical endocrinology and metabolism.

[22]  A. Kántor,et al.  A new nomenclature for B cells. , 1991, Immunology today.

[23]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[24]  A. Sher,et al.  Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.

[25]  A. Sher,et al.  Diversity of Cytokine Synthesis and Function of Mouse CD4+ T Cells , 1991, Immunological reviews.

[26]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[28]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[29]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[30]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.

[31]  T. Mosmann,et al.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells , 1990, The Journal of experimental medicine.

[32]  T. Mosmann,et al.  Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. , 1990, Journal of immunology.

[33]  H. Rugo,et al.  Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.

[34]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[35]  R. Sartor.  Role of Intestinal Microflora in Initiation and Perpetuation of Inflammatory Bowel Disease , 1990 .

[36]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[37]  K. Rajewsky,et al.  Flow cytometric analysis of cell proliferation dynamics in the B cell compartment of the mouse. , 1989, International immunology.

[38]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[39]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[40]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[41]  A. Bradley.  Production and analysis of chimeric mice , 1987 .

[42]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Paul,et al.  Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. A. Wall,et al.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.

[45]  G. Dreesman,et al.  Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). , 1983, Journal of immunological methods.

[46]  R. Coffman.  Surface Antigen Expression and Immunoglobulin Gene Rearrangement During Mouse pre‐B Cell Development , 1983, Immunological reviews.

[47]  T. Springer,et al.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. , 1981, Journal of immunology.

[48]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  L. Herzenberg,et al.  Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens * , 1979, Immunological reviews.

[50]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.